SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
Cheng Liu(Qingdao University), Yidong Fan(Guangxi University), Dawei Xu(Karolinska University Hospital), Chang Wang(Allen Institute for Brain Science), Li Liu(Shihezi University), Zhonghua Xu(Jiangxi University of Traditional Chinese Medicine), Kun Wang(Union Hospital), Qi Shen(Qingdao University), Keqiang Yan(Qilu Hospital of Shandong University), Hainan Liu(Qingdao University), Hongbo Ren(Qilu Hospital of Shandong University), Xiaoqing Sun(Qingdao University), Sanyuan Hu(Shandong University), Jie Chen(Memorial Sloan Kettering Cancer Center), Ji‐Kai Liu(South Central Minzu University)
Cited by 79
Related Papers
Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis
|The Lancet|2014|3.2k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Lipids and Lipid Derivatives for RNA Delivery
|Chemical Reviews|2021|592
Large-Area, Flexible, Transparent, and Long-Lived Polymer-Based Phosphorescence Films
|Journal of the American Chemical Society|2021|513
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
|Cancer Research|2009|490